Hong Kong Renewable Energy Stock News

China Medical System Holdings (SEHK:867) just cleared a meaningful hurdle, with regulators accepting its New Drug Application for Y-3 for Injection after a successful Phase III trial in acute ischemic stroke patients. See our latest analysis for China Medical System Holdings. Despite a softer 30 day share price return and some recent consolidation, China Medical System Holdings still sits at HK$13.40, with strong upward share price return year to date and a robust multi year total shareholder...

Akeso has recently reported a series of oncology milestones, including FDA approval to start a global Phase III trial of cadonilimab in advanced HER2‑negative gastric cancer and new Phase II/III data on ivonescimab in triple‑negative breast cancer and squamous non‑small cell lung cancer. Together, these updates underscore Akeso’s push to position its bispecific antibodies as potential new standards of care across multiple solid tumors, supported by both efficacy and quality‑of‑life...

In December 2025, RemeGen Co., Ltd was added to the Shanghai Stock Exchange Health Care Sector Index, marking its inclusion among China’s listed healthcare names tracked by this benchmark. This index inclusion can increase RemeGen’s visibility to institutional investors that track or reference sector indices, potentially influencing how the company is positioned in healthcare-focused portfolios. With this new index inclusion as a backdrop, we’ll examine how RemeGen’s expanding profile within...

Key Insights Lingbao Gold Group's significant retail investors ownership suggests that the key decisions are influenced...

Lenovo Group (SEHK:992) just rolled out a sweeping lineup of AI ready storage, virtualization, and data management offerings, a strategic push that could gradually reshape how investors view its infrastructure and services growth story. See our latest analysis for Lenovo Group. Against that backdrop, Lenovo’s HK$9.66 share price reflects a mixed year, with recent share price returns under pressure but a solid 1 year total shareholder return of about 9.8 percent and strong three year...

Earlier in December, Giant Biogene Holding announced a share repurchase plan, following recent analyst coverage from Citic Securities, Citi and UBS. The buyback move is being read as a signal of management confidence and a direct attempt to enhance shareholder value. With the share repurchase plan now in place, we’ll explore how this capital allocation decision shapes Giant Biogene’s broader investment narrative. AI is about to change healthcare. These 30 stocks are working on everything...

We can readily understand why investors are attracted to unprofitable companies. For example, Tai Kam Holdings...

Key Insights Hysan Development's significant private companies ownership suggests that the key decisions are influenced...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...

It's not a stretch to say that Luk Fook Holdings (International) Limited's ( HKG:590 ) price-to-earnings (or "P/E...

As global markets react to interest rate adjustments and economic uncertainties, investors are increasingly looking toward alternative investment opportunities. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

China Resources Beer (Holdings) (SEHK:291) just picked up top honors in both Corporate Governance and ESG Excellence Awards, a signal that its sustainability and oversight practices are increasingly aligned with long term, risk aware investors. See our latest analysis for China Resources Beer (Holdings). At around HK$27.0, the shares have delivered an 11.34% year to date share price return. However, the 3 year total shareholder return of minus 44.69% shows the longer term momentum has been...

ASMPT Limited ( HKG:522 ), is not the largest company out there, but it received a lot of attention from a substantial...

Sundy Service Group Co. Ltd's ( HKG:9608 ) price-to-earnings (or "P/E") ratio of 30.6x might make it look like a strong...

DT Capital Limited's (HKG:356) stock price has dropped 13% in the previous week, but insiders who sold HK$2.8m in stock...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

It is hard to get excited after looking at HBM Holdings' (HKG:2142) recent performance, when its stock has declined 17...

Insiders who bought Regent Pacific Group Limited ( HKG:575 ) stock lover the last 12 months are probably not as...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Looking at CARsgen Therapeutics Holdings Limited's ( HKG:2171 ) insider transactions over the last year, we can see...

Sunlight (1977) Holdings Limited ( HKG:8451 ) shareholders have had their patience rewarded with a 42% share price jump...

Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed. For...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...